Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Dementia01:30

Dementia

660
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
660
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

1.9K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.9K
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

1.1K
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
1.1K
Regulation of Stroke Volume01:27

Regulation of Stroke Volume

5.5K
The regulation of stroke volume, which is the amount of blood the heart pumps out during each heartbeat, is critical for maintaining a healthy circulatory system. Stroke volume is influenced by three main factors: preload, contractility, and afterload.
Preload refers to the degree of stretch on the heart before it contracts. It's analogous to the stretching of a rubber band; the more it's stretched, the more forcefully it snaps back. This concept is encapsulated in the Frank-Starling law of the...
5.5K
Vascular Spasm01:16

Vascular Spasm

4.6K
The vascular phase, also known as vasospasm, is the initial stage of hemostasis, crucial for preventing excessive bleeding when a blood vessel is injured. After a vessel is cut, nerves in the damaged area trigger pain and other sensory impulses. Simultaneously, the smooth muscles in the vessel wall contract, resulting in a vascular spasm. This contraction reduces the vessel's diameter at the injury site, slowing or stopping blood loss through the vessel wall. Vascular spasms typically last...
4.6K
Visual Agnosia01:12

Visual Agnosia

1.6K
Visual agnosia is a condition characterized by the inability to recognize visually presented objects despite having normal vision. For instance, a person with visual agnosia can describe the shape and color of an object but cannot identify or name it. This impairment does not affect their visual field, acuity, color vision, brightness discrimination, language, or memory. An example of this condition in a social setting is someone at a dinner party asking for "that silver thing with a round...
1.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Validation of the care partner stress scale in the CAN-PROTECT study.

Journal of Alzheimer's disease : JAD·2026
Same author

The association between autistic traits and trajectories of anxiety in middle-aged and older adults: an 8-year growth mixture model analysis.

Nature. Mental health·2026
Same authorSame journal

Mild Behavioural Impairment and Everyday Functioning in Cognitively Unimpaired Older Adults: Evidence From the CAN-PROTECT Study.

Journal of geriatric psychiatry and neurology·2026
Same author

Cross-sectional and longitudinal associations of self-perceptions of aging with physical activity in multimorbidity: The role of depressive symptoms.

Archives of gerontology and geriatrics·2026
Same author

Stakeholder perspectives on the potential benefits, risks, and implications of an interactive cognitive monitoring app for the identification and monitoring of cognitive decline in adults at risk of dementia.

BMC health services research·2026
Same author

Racial and Ethnic Representation in Dementia Clinical Trials Registered on ClinicalTrials.gov in the United States, United Kingdom, and Canada.

International journal of geriatric psychiatry·2026
Same journal

Identifying the Barriers and Facilitators to Clinical Implementation of Risk Prediction Tools for Dementia Across UK Primary Care: A Stakeholder Interview Study.

Journal of geriatric psychiatry and neurology·2026
Same journal

Caregiver Reports of Lucid Episodes in Alzheimer's Dementia and Lewy Body Dementias.

Journal of geriatric psychiatry and neurology·2026
Same journal

Neuropsychologists' Engagement With and Cognitive Assessment in Parkinson's Disease: A Mixed Methods Australian Investigation.

Journal of geriatric psychiatry and neurology·2026
Same journal

Attention Networks Connectivity After Cognitive Rehabilitation in Alzheimer's Disease.

Journal of geriatric psychiatry and neurology·2026
Same journal

Associations Between Immigration-Related Factors and Cognition Among Hispanics, the HABS-HD Study.

Journal of geriatric psychiatry and neurology·2026
See all related articles

Related Experiment Video

Updated: Mar 16, 2026

Author Spotlight: Modeling Vascular Contributions to Alzheimer's Disease in Transgenic Mice
04:29

Author Spotlight: Modeling Vascular Contributions to Alzheimer's Disease in Transgenic Mice

Published on: May 17, 2024

1.2K

Update on Vascular Dementia.

Ayesha Khan1, Raj N Kalaria2, Anne Corbett3

  • 1Wolfson Centre for Age Related Diseases, Guys Campus, London, United Kingdom of Great Britain and Northern Ireland Institute of NanoBioTechnology, Johns Hopkins University, Baltimore, MD, USA.

Journal of Geriatric Psychiatry and Neurology
|August 10, 2016
PubMed
Summary
This summary is machine-generated.

Vascular dementia (VaD) involves cognitive decline due to impaired brain blood flow. Managing vascular risk factors like high blood pressure is key to preventing VaD and its associated memory and reasoning problems.

Keywords:
cerebrovascular diseasedementiavascular dementia

More Related Videos

Using Retinal Imaging to Study Dementia
09:17

Using Retinal Imaging to Study Dementia

Published on: November 6, 2017

22.4K
A Mouse Model for Vascular Cognitive Impairment and Dementia Based on Needle-guided Asymmetric Bilateral Common Carotid Artery Stenosis
05:12

A Mouse Model for Vascular Cognitive Impairment and Dementia Based on Needle-guided Asymmetric Bilateral Common Carotid Artery Stenosis

Published on: November 22, 2024

1.6K

Related Experiment Videos

Last Updated: Mar 16, 2026

Author Spotlight: Modeling Vascular Contributions to Alzheimer's Disease in Transgenic Mice
04:29

Author Spotlight: Modeling Vascular Contributions to Alzheimer's Disease in Transgenic Mice

Published on: May 17, 2024

1.2K
Using Retinal Imaging to Study Dementia
09:17

Using Retinal Imaging to Study Dementia

Published on: November 6, 2017

22.4K
A Mouse Model for Vascular Cognitive Impairment and Dementia Based on Needle-guided Asymmetric Bilateral Common Carotid Artery Stenosis
05:12

A Mouse Model for Vascular Cognitive Impairment and Dementia Based on Needle-guided Asymmetric Bilateral Common Carotid Artery Stenosis

Published on: November 22, 2024

1.6K

Area of Science:

  • Neurology
  • Geriatrics
  • Vascular Medicine

Background:

  • Vascular dementia (VaD) is a significant cause of dementia, characterized by cognitive deficits resulting from cerebrovascular disease.
  • It often co-occurs with other neurodegenerative conditions, such as Alzheimer disease, complicating diagnosis and management.
  • Impaired blood flow and vascular damage in the brain underlie VaD, often stemming from events like stroke.

Purpose of the Study:

  • To provide an update on the subtypes of vascular dementia.
  • To detail the complex presentations, pathological lesions, and diagnostic challenges associated with VaD.
  • To discuss current understanding and approaches to the prevention and treatment of VaD.

Main Methods:

  • Review of current literature on vascular dementia subtypes.
  • Analysis of pathological findings and lesion locations in the brain.
  • Examination of diagnostic criteria and challenges.
  • Assessment of risk factors and preventative strategies.
  • Evaluation of therapeutic interventions for VaD.

Main Results:

  • VaD encompasses diverse subtypes with varied clinical presentations and underlying pathologies.
  • Diagnosis is challenging due to lesion heterogeneity and location.
  • Vascular risk factors, including hypertension, hyperlipidemia, and smoking, are strongly associated with VaD development.
  • Effective management of these risk factors is crucial for prevention.

Conclusions:

  • Controlling vascular risk factors is paramount in reducing the incidence of VaD.
  • Further research is needed to refine diagnostic approaches and therapeutic strategies for different VaD subtypes.
  • A comprehensive understanding of VaD's etiology and pathology is essential for improved patient outcomes.